Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma

NCT01569750

Conditions
CD20-positive B-cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • New York, United States
  • Rochester, New York, United States
  • Nashville, Tennessee, United States
  • Houston, Texas, United States
View Trial Details
Completed

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy
  • U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy
  • Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy
  • CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy
View all 16 locations
View Trial Details
Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
View Trial Details
Completed

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

NCT00790036

Conditions
Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers SC Chandler, Arizona, United States
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3) La Jolla, California, United States
  • USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4) Los Angeles, California, United States
View all 202 locations
View Trial Details

Related conditions